Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216743032> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W3216743032 startingPage "41" @default.
- W3216743032 abstract "BACKGROUND Hypertension guidelines emphasize the selection of antihypertensive treatment on the basis of absolute cardiovascular risk. Moreover, compelling and possible indications for each antihypertensive drug class are recommended for patients with other concomitant conditions. The aim of the present study was to analyze the relationship between the cardiovascular risk profile and co-morbid conditions on antihypertensive drug class use. METHODS This is an observational, multicenter, cross-sectional study performed in 2,850 essential hypertensive patients. Antihypertensive drug treatment has been evaluated on the basis of the presence of other cardiovascular risk factors, target organ damage or cardiovascular diseases, as well as the absolute cardiovascular risk profile. RESULTS Patients with diabetes were treated more frequently with calcium channel blockers (CCB) and ACE inhibitors. However, the presence of hypercholesterolemia or smoking habit did not influence the use of antihypertensive drug classes. The presence of cerebrovascular disease increased the use of CCB and ACE inhibitors, whereas coronary disease increased the use of CCB and betablockers. The use of diuretics and angiotensin II receptor antagonists was increased in patients with cardiac failure, whereas neither betablockers nor ACE inhibitors were affected by this concomitant disease. Patients with the highest cardiovascular risk received more antihypertensive treatment than those with lower risk, but this was not accompanied by switching from old classes to new ones. CONCLUSION Cardiovascular risk profile seems to have little influence on the use of antihypertensive drug classes, particularly the presence of hypercholesterolemia or cardiac failure. It seems adequate to emphasize the necessity of an individualization of antihypertensive treatment, based on the presence of concomitant conditions that influence the absolute cardiovascular risk." @default.
- W3216743032 created "2021-12-06" @default.
- W3216743032 creator A5014922443 @default.
- W3216743032 creator A5043883265 @default.
- W3216743032 creator A5062327357 @default.
- W3216743032 creator A5069730469 @default.
- W3216743032 date "2000-06-10" @default.
- W3216743032 modified "2023-09-29" @default.
- W3216743032 title "[Relationship between cardiovascular risk profile and anti-hypertensive drug use. GEDEC (Spanish group of cardiovascular studies]." @default.
- W3216743032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10934691" @default.
- W3216743032 hasPublicationYear "2000" @default.
- W3216743032 type Work @default.
- W3216743032 sameAs 3216743032 @default.
- W3216743032 citedByCount "3" @default.
- W3216743032 crossrefType "journal-article" @default.
- W3216743032 hasAuthorship W3216743032A5014922443 @default.
- W3216743032 hasAuthorship W3216743032A5043883265 @default.
- W3216743032 hasAuthorship W3216743032A5062327357 @default.
- W3216743032 hasAuthorship W3216743032A5069730469 @default.
- W3216743032 hasConcept C126322002 @default.
- W3216743032 hasConcept C134018914 @default.
- W3216743032 hasConcept C164705383 @default.
- W3216743032 hasConcept C23131810 @default.
- W3216743032 hasConcept C2778198053 @default.
- W3216743032 hasConcept C2779134260 @default.
- W3216743032 hasConcept C2779384505 @default.
- W3216743032 hasConcept C2780035454 @default.
- W3216743032 hasConcept C2780192228 @default.
- W3216743032 hasConcept C555293320 @default.
- W3216743032 hasConcept C71924100 @default.
- W3216743032 hasConcept C84393581 @default.
- W3216743032 hasConcept C98274493 @default.
- W3216743032 hasConceptScore W3216743032C126322002 @default.
- W3216743032 hasConceptScore W3216743032C134018914 @default.
- W3216743032 hasConceptScore W3216743032C164705383 @default.
- W3216743032 hasConceptScore W3216743032C23131810 @default.
- W3216743032 hasConceptScore W3216743032C2778198053 @default.
- W3216743032 hasConceptScore W3216743032C2779134260 @default.
- W3216743032 hasConceptScore W3216743032C2779384505 @default.
- W3216743032 hasConceptScore W3216743032C2780035454 @default.
- W3216743032 hasConceptScore W3216743032C2780192228 @default.
- W3216743032 hasConceptScore W3216743032C555293320 @default.
- W3216743032 hasConceptScore W3216743032C71924100 @default.
- W3216743032 hasConceptScore W3216743032C84393581 @default.
- W3216743032 hasConceptScore W3216743032C98274493 @default.
- W3216743032 hasIssue "2" @default.
- W3216743032 hasLocation W32167430321 @default.
- W3216743032 hasOpenAccess W3216743032 @default.
- W3216743032 hasPrimaryLocation W32167430321 @default.
- W3216743032 hasVolume "115" @default.
- W3216743032 isParatext "false" @default.
- W3216743032 isRetracted "false" @default.
- W3216743032 magId "3216743032" @default.
- W3216743032 workType "article" @default.